FindTrial
Sign In

Study on the effect of "fake feeding" behavior in the treatment of urinary stones

Study on the effect of "fake feeding" behavior in the treatment of urinary stones

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081391
Enrollment
Unknown
Registered
2024-02-29
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary stones

Interventions

Group A (Phase 1):One bag of Lithagogue Powder each time, 3 times daily Chewing gum for the full 15min period each time, 3 times daily Taken daily until spontaneous stone passage, up to a maximum of 2
Group B (Phase 1):One bag of Lithagogue Powder each time, 3 times daily Taken daily until spontaneous stone passage, up to a maximum of 28d or the need for intervention
A group (Phase 2):One bag of Lithagogue Powder each time, 3 times daily Chewing gum for the full 15min period each time, 3 times daily Taken daily until spontaneous stone passage, up to a maximum of 2
B group (Phase 2):One bag of Lithagogue Powder each time, 3 times daily Taken daily until spontaneous stone passage, up to a maximum of 28d or the need for intervention

Sponsors

Dongying People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Adults, 18–60 yr; emergency admission for renal colic; presence of a single ureteral stone confirmed by plain abdominal radiography (kidney–ureters–bladder), urinary ultrasonography, and/or noncontrast computed tomography (CT); a stone in the ureter, with a dimension of 4–7 mm; and a unilateral presentation.

Exclusion criteria

Exclusion criteria: Fever; urinary tract infections; severe hydronephrosis; renal insufficiency; abnormal anatomy,such as a solitary kidney, horseshoe kidney, or a duplex urinary system; urethrostenosis; a history of ureter strictures; diabetes mellitus; hypotension (systolic blood pressure <100 mmHg); known or suspected pregnancy; current use of a-adrenoceptor antagonists; and a previous history of ipsilateral ureteral surgery, known or suspected allergy to the study medications

Design outcomes

Primary

MeasureTime frame
Stone clear rate;Ureteral Stent Symptom Score;Stone discharge time;Transfer surgery treatment rate;—

Secondary

MeasureTime frame
Visual Analog Pain Scale;—

Countries

China

Contacts

Public ContactWei Jiang

Dongying People's Hospital

jwmnwk@163.com+86 183 6691 0841

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026